High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis
Related Experiment Videos
Journal of Neurology, Neurosurgery, and Psychiatry
|October 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
ASNR-ESNR White Paper on Sustainability in Neuroradiology.
AJNR. American journal of neuroradiology·2026
Diagnostic pitfalls and complex cases in MS.
Revue neurologique·2026
The value of manual MRI measurements of brain and spinal cord for daily clinical practice in multiple sclerosis subjects: A scoping review.
Multiple sclerosis and related disorders·2025
Synthetic MRI in Progressive MS: Associations with Disability.
AJNR. American journal of neuroradiology·2025
PABPN1 pathogenic expansion in the UK Biobank: reframing genetic prevalence of oculopharyngeal muscular dystrophy.
Journal of neurology, neurosurgery, and psychiatry·2026
Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP study.
Journal of neurology, neurosurgery, and psychiatry·2026
Stroke recurrence after primary intracerebral haemorrhage: a population-based study of clinical and MRI factors associated with recurrence.
Journal of neurology, neurosurgery, and psychiatry·2026
Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.
Journal of neurology, neurosurgery, and psychiatry·2026
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.
Journal of neurology, neurosurgery, and psychiatry·2026
MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.
Journal of neurology, neurosurgery, and psychiatry·2026